Director John J Regazzi filed a Form 4 with the SEC on November 18, 2026, disclosing the acquisition of stock options to purchase common stock of Research Solutions, Inc. (NASDAQ:RSSS), with a transaction date of November 16, 2026.

Key Highlights

  • Reporting person: John J Regazzi, identified as a Director of Research Solutions, Inc.
  • Securities acquired: Options to purchase 15,000 shares of common stock, acquired with transaction code A (acquired).
  • Exercise price: $1.89 per share, with an expiration date of November 15, 2036.
  • Price paid: $0 for the derivative security at acquisition.
  • Post-transaction holdings: 15,000 derivative securities beneficially owned following the reported transaction, held directly.
  • Vesting schedule: 1/3 of the options vest on November 16, 2027, and 1/12 vest on the last day of each quarter beginning December 31, 2027, until fully vested.

Research Solutions Director Regazzi Receives 15,000 Stock Options

According to the Form 4 filing, John J Regazzi, a Director of Research Solutions, Inc., acquired options to purchase 15,000 shares of common stock on November 16, 2026. The filing identifies the transaction code as A, indicating acquisition. The exercise price of the options is $1.89 per share, and the options expire on November 15, 2036. The price of the derivative security at the time of the transaction was reported as $0.

The filing discloses a specific vesting schedule for the options. As stated in the explanation of responses, "1/3rd of the options vest on November 16, 2027 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2027 until fully vested." Following the reported transaction, Regazzi beneficially owns 15,000 derivative securities in a direct ownership form, according to the filing.

The Form 4 was filed by one reporting person and was signed by David Kutil as Attorney-in-Fact on November 18, 2026. No non-derivative securities transactions were reported in Table I of the filing. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as that checkbox was not selected.

What Was Disclosed

Research Solutions, Inc. Director John J Regazzi reported the acquisition of 15,000 stock options at an exercise price of $1.89, expiring November 15, 2036, with a graduated vesting schedule beginning November 16, 2027, in a Form 4 filed November 18, 2026.